Literature DB >> 25955953

Implant Prosthetic Rehabilitation in Controlled HIV-Positive Patients: A Prospective Longitudinal Study with 1-Year Follow-Up.

Enrico F Gherlone1, Paolo Capparé1, Simona Tecco1, Elisabetta Polizzi1, Giuseppe Pantaleo2, Giorgio Gastaldi3, Maria Gabriella Grusovin4.   

Abstract

PURPOSE: The clinical trial aimed to evaluate the survival of implant-prosthetic rehabilitation in controlled HIV-positive patients.
MATERIALS AND METHODS: This mono-centric study included HIV patients with a stable disease, requiring implant rehabilitation, with good oral hygiene. Each patient received at least one dental implant. After 90 days in the upper jaw and 60 days in the lower jaw, the appropriate prosthesis was delivered.Primary outcome measures were prosthetic failures, implant failures, peri-implant marginal bone level changes (MBLCs), and biological complications (peri-implantitis, pus, pain, paresthesia). Data were recorded before the intervention (T0), and 6 (T1) and 12 months (T2) after.
RESULTS: Implants were positioned in 68 patients (22 females and 46 males; 194 implants). Two dropouts occurred for exacerbation of the disease before the sixth month of follow-up, and 66 patients (with 190 implants) completed the study. Forty-eight patients (70.6%) received total removable dentures; 11 patients (16.2%) received partial prosthesis, and nine patients (13.2%) received single elements.Implant failure occurred in nine patients (15 fixtures out of 190). These were early implant failures due to primary infection (five fixtures out of 190: 2.6%) and to peri-implantitis (10 fixtures out of 190: 5.2%). Prosthetic failure was registered in two patients (3% of patients) due to the loss of all the fixtures. Pus and pain were observed in 4/7 and 3/7 patients with peri-implantitis, respectively. No fractures of fixtures or paresthesia were registered. At T2, the mean peri-implant MBLC was -1.19 ± 0.87 mm.
CONCLUSIONS: Within its limitations, the study showed that in a well-controlled population of HIV patients implant rehabilitation can be a suitable options with results slightly worse to those obtained in normal population. A higher incidence of peri implant infections in the first six months was present pointing to the need of a proper protocol for infection control.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  AIDS; HIV; implant; implant survival; implantology; osseointegration; peri-implantitis

Mesh:

Substances:

Year:  2015        PMID: 25955953     DOI: 10.1111/cid.12353

Source DB:  PubMed          Journal:  Clin Implant Dent Relat Res        ISSN: 1523-0899            Impact factor:   3.932


  18 in total

1.  Prosthetic management of patients with oro-maxillo-facial defects: a long-term follow-up retrospective study.

Authors:  G Gastaldi; L Palumbo; C Moreschi; E F Gherlone; P Capparé
Journal:  Oral Implantol (Rome)       Date:  2017-11-30

2.  Metallothionein 3 Promotes Osteoblast Differentiation in C2C12 Cells via Reduction of Oxidative Stress.

Authors:  Santie Li; Myeong-Ji Kim; Sung-Ho Lee; Litai Jin; Weitao Cong; Hye-Gwang Jeong; Kwang-Youl Lee
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

3.  Dental implants in immunocompromised patients: a systematic review and meta-analysis.

Authors:  Fabian Duttenhoefer; Marc Anton Fuessinger; Yasmin Beckmann; Rainer Schmelzeisen; Knut A Groetz; Martin Boeker
Journal:  Int J Implant Dent       Date:  2019-11-28

4.  IgG4-Related Disease of the Oral Cavity. Case Series from a Large Single-Center Cohort of Italian Patients.

Authors:  Andrea Rampi; Marco Lanzillotta; Gaia Mancuso; Alessandro Vinciguerra; Lorenzo Dagna
Journal:  Int J Environ Res Public Health       Date:  2020-11-05       Impact factor: 3.390

5.  Hydroxyapatite Formation on Coated Titanium Implants Submerged in Simulated Body Fluid.

Authors:  Tatiana Aviles; Shu-Min Hsu; Arthur Clark; Fan Ren; Chaker Fares; Patrick H Carey; Josephine F Esquivel-Upshaw
Journal:  Materials (Basel)       Date:  2020-12-08       Impact factor: 3.623

6.  Bioactive Coatings Based on Hydroxyapatite, Kanamycin, and Growth Factor for Biofilm Modulation.

Authors:  Oana Gherasim; Alexandru Mihai Grumezescu; Valentina Grumezescu; Irina Negut; Marius Florin Dumitrescu; Miruna Silvia Stan; Ionela Cristina Nica; Alina Maria Holban; Gabriel Socol; Ecaterina Andronescu
Journal:  Antibiotics (Basel)       Date:  2021-02-05

7.  Risk Perception of Septic Shock with Multiple Organ Failure Due to Acute Exacerbation of an Infectious Dental Disease.

Authors:  Hikaru Sato; Takashi Tamanoi; Takuya Suzuki; Hikaru Moriyama; Shota Abe; Kenji Yoshida; Hiroyoshi Kawaai; Shinya Yamazaki
Journal:  Ther Clin Risk Manag       Date:  2021-04-22       Impact factor: 2.423

8.  Digital Smile Designed Computer-Aided Surgery versus Traditional Workflow in "All on Four" Rehabilitations: A Randomized Clinical Trial with 4-Years Follow-Up.

Authors:  Francesca Cattoni; Luca Chirico; Alberto Merlone; Michele Manacorda; Raffaele Vinci; Enrico Felice Gherlone
Journal:  Int J Environ Res Public Health       Date:  2021-03-26       Impact factor: 3.390

9.  Expression Analysis of FGF/FGFR and FOX Family Proteins in Mucosal Tissue Obtained from Orofacial Cleft-Affected Children.

Authors:  Māra Pilmane; Nityanand Jain; Zane Vitenberga-Verza
Journal:  Biology (Basel)       Date:  2021-05-10

10.  Evaluation of IL6, IL10 and VDR alleles distribution in an Italian large sample of subjects affected by chronic periodontal disease.

Authors:  Scapoli Luca; Carinci Francesco; Mucchi Damiano; Nota Alessandro; Caruso Silvia; Rossi Diego; Romano Michele; Severino Marco
Journal:  Int J Immunopathol Pharmacol       Date:  2019 Jan-Dec       Impact factor: 3.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.